Ligand · 8E8
8E8 · 1-[(3~{R})-3-[4-azanyl-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one
8E8, 1-[(3~{R})-3-[4-azanyl-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one (C25 H26 N6 O2, 442.5 g/mol), in the MolNFT structures on GenesisL1: bound in 3 records (2 PDB entries). Every binding site with its…
- Component
- 8E8
- Formula
- C25 H26 N6 O2
- Class
- ligand
- Structures
- 3
- PDB entries
- 2
Binding sites
8E8 in 3 structures; the first of them:
- 6YG2 · Crystal structure of MKK7 (MAP2K7) in complex with ibrutnib, with covalent and allosteric… · 8E8 A514 · binds MET142, GLY143, SER144, GLY145, LYS165, ILE179, ASP182, LEU183 and 11 more
- 5P9J · BTK1 cocrystallized with ibrutinib · 8E8 A701 · binds LEU408, VAL416, ALA428, LYS430, MET449, ILE472, THR474, GLU475 and 10 more
- 6YG2 · Crystal structure of MKK7 (MAP2K7) in complex with ibrutnib, with covalent and allosteric… · 8E8 A514 · binds MET142, GLY143, SER144, GLY145, LYS165, ILE179, ASP182, LEU183 and 11 more
Residues it binds most
MET 3, LEU 3, GLU 3, GLY 3, ILE 3, LYS 3, SER 3, ASP 3, CYS 3, PHE 3 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.